As a result of participating in this lecture learners should have a working knowledge of the following topics, essential to competency in addiction medicine and identify areas where more study may be needed:
- A description of the pharmacodynamics of common substances of abuse.;
- Discussion of specifics of pharmacological approaches to treatment of addictions, including a general overview of available options, what is FDA approved, what is used in other countries (if of interest) and new medications in development.
Thomas Kosten, MD
Dr. Kosten is the JH Waggoner Chair & Professor of Psychiatry, Pharmacology, Neuroscience and Immunology & Pathology at Baylor and co-director of the Dan L. Duncan Institute for Clinical and Translational Research. He also is Distinguished Professor of Psychiatry at Peking University Medical School and Professor of Epidemiology and of Behavioral Sciences at MD Anderson Cancer Center. He established the Division of Addictions at Baylor and Yale and directs their NIH Medications Development Center for substance abuse. He is past president of both the American Academy of Addiction Psychiatry and the College on Problems of Drug Dependence. He is the Editor for the American Journal on Addictions.
Reckitt Benckiser: Consulting Fees, Honoraria, Speakers Bureau
- 0.50 NCCPA
- 0.50 AAPA
- 0.50 AMA Category 1
- 0.50 CAADAC